Patent ID: 11903951
Assignee: M ET P PHARMA AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 13:
14. A method for vaccinating a subject against a condition comprising nasally administering the composition of claim 1 to a subject in need thereof, wherein:
(a) the condition is influenza, and the active agent is live attenuated influenza virus, inactivated virus, or viral antigens;
(b) The condition is hepatitis B, and the active agent is Hepatitis B virus (HBV), surface hepatitis B antigens (HBsAg), and/or core hepatitis B antigens (HBcAg); or
(c) The condition is meningitis, and the active agent is meningococcal polysaccharide vaccine (MPSV4, polysaccharide from the surface of the meningococcal bacteria), meningococcal conjugate vaccine (MCV4, polysaccharide chemically bonded to protein) and/or meningococcal serogroup B vaccine (MenB, which contains four proteins taken from group B Neisseria meningitidis bacteria).